These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 23662605)

  • 1. Nanocurcumin: a promising therapeutic advancement over native curcumin.
    Flora G; Gupta D; Tiwari A
    Crit Rev Ther Drug Carrier Syst; 2013; 30(4):331-68. PubMed ID: 23662605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing Curcumin Oral Bioavailability Through Nanoformulations.
    Ipar VS; Dsouza A; Devarajan PV
    Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):459-480. PubMed ID: 30771095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in curcumin-based nanoformulations in diabetes.
    Ataei M; Gumpricht E; Kesharwani P; Jamialahmadi T; Sahebkar A
    J Drug Target; 2023 Aug; 31(7):671-684. PubMed ID: 37354074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability.
    Wu X; Xu J; Huang X; Wen C
    Drug Dev Ind Pharm; 2011 Jan; 37(1):15-23. PubMed ID: 20738181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.
    Shukla M; Jaiswal S; Sharma A; Srivastava PK; Arya A; Dwivedi AK; Lal J
    Drug Dev Ind Pharm; 2017 May; 43(5):847-861. PubMed ID: 27648633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders.
    Tagde P; Tagde P; Islam F; Tagde S; Shah M; Hussain ZD; Rahman MH; Najda A; Alanazi IS; Germoush MO; Mohamed HRH; Algandaby MM; Nasrullah MZ; Kot N; Abdel-Daim MM
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles.
    Adahoun MA; Al-Akhras MH; Jaafar MS; Bououdina M
    Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):98-107. PubMed ID: 26747522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of Curcumin-Loaded PEG-PLGA Nanoparticles by GSH Functionalization: Investigation of the Internalization Pathway in Neuronal Cells.
    Paka GD; Ramassamy C
    Mol Pharm; 2017 Jan; 14(1):93-106. PubMed ID: 27744707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin nanoparticles: preparation, characterization, and antimicrobial study.
    Bhawana ; Basniwal RK; Buttar HS; Jain VK; Jain N
    J Agric Food Chem; 2011 Mar; 59(5):2056-61. PubMed ID: 21322563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.
    Shome S; Talukdar AD; Choudhury MD; Bhattacharya MK; Upadhyaya H
    J Pharm Pharmacol; 2016 Dec; 68(12):1481-1500. PubMed ID: 27747859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced nanocurcumin toxicity against (PC3) tumor and microbial by using magnetic field in vitro.
    Aldahoun MA; Jaafar MS; Al-Akhras MH; Bououdina M
    Artif Cells Nanomed Biotechnol; 2017 Jun; 45(4):843-853. PubMed ID: 27137748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocurcumin: A Promising Candidate for Therapeutic Applications.
    Karthikeyan A; Senthil N; Min T
    Front Pharmacol; 2020; 11():487. PubMed ID: 32425772
    [No Abstract]   [Full Text] [Related]  

  • 13. Chitosan-based delivery systems for curcumin: A review of pharmacodynamic and pharmacokinetic aspects.
    Saheb M; Fereydouni N; Nemati S; Barreto GE; Johnston TP; Sahebkar A
    J Cell Physiol; 2019 Aug; 234(8):12325-12340. PubMed ID: 30697728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria.
    Dende C; Meena J; Nagarajan P; Nagaraj VA; Panda AK; Padmanaban G
    Sci Rep; 2017 Aug; 7(1):10062. PubMed ID: 28855623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats.
    Zou P; Helson L; Maitra A; Stern ST; McNeil SE
    Mol Pharm; 2013 May; 10(5):1977-87. PubMed ID: 23534919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan Encapsulation Enhances the Bioavailability and Tissue Retention of Curcumin and Improves its Efficacy in Preventing B[a]P-induced Lung Carcinogenesis.
    Vijayakurup V; Thulasidasan AT; Shankar G M; Retnakumari AP; Nandan CD; Somaraj J; Antony J; Alex VV; Vinod BS; Liju VB; Sundaram S; Kumar GSV; Anto RJ
    Cancer Prev Res (Phila); 2019 Apr; 12(4):225-236. PubMed ID: 30760502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of nanocurcumin based hybrid virosomes as a drug delivery vehicle with enhanced anticancerous activity and reduced toxicity.
    Kumar V; Kumar R; Jain VK; Nagpal S
    Sci Rep; 2021 Jan; 11(1):368. PubMed ID: 33432002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileishmanial activity of nanocurcumin.
    Samim M; Naqvi S; Arora I; Ahmad FJ; Maitra A
    Ther Deliv; 2011 Feb; 2(2):223-30. PubMed ID: 22833948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier.
    Nair KL; Thulasidasan AK; Deepa G; Anto RJ; Kumar GS
    Int J Pharm; 2012 Apr; 425(1-2):44-52. PubMed ID: 22266528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin nanoformulations: a future nanomedicine for cancer.
    Yallapu MM; Jaggi M; Chauhan SC
    Drug Discov Today; 2012 Jan; 17(1-2):71-80. PubMed ID: 21959306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.